ReproNovo specializes in reproductive health and women's health.
ReproNovo has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
ReproNovo's investors include Jeito Capital, Ysios Capital, M Ventures, ALSA Ventures, AXA Alternative Investments.
ReproNovo is headquartered in Lausanne, Switzerland.
ReproNovo specializes in reproductive health and women's health.
ReproNovo is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ReproNovo — Funding & Investors." VCBacked, May 21, 2025, https://www.vcbacked.co/company/repronovo. Accessed August 14, 2026.
VCBacked. (2025). ReproNovo — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/repronovo
{{cite web |title=ReproNovo — Funding & Investors |url=https://www.vcbacked.co/company/repronovo |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated